November 7, 2022
Ann Romaker, MD, of the Division of Pulmonary, Critical Care and Sleep Medicine in the UC College of Medicine was interviewed by Fox19 about the end of daylight saving time this past weekend.
November 6, 2023
The semi-annual changing of clocks by an hour in the spring in fall has detrimental health impacts and some experts say it's time for that practice to be put to bed. Ann Romaker, MD, of the Division of Pulmonary, Critical Care and Sleep Medicine at the UC College of Medicine, spoke to WVXU on the topic.
June 25, 2024
The University of Cincinnati's Wesley Baas spoke with Yahoo News and the Cincinnati Enquirer about a new male birth control gel that could be close to receiving FDA approval.
May 26, 2023
University of Cincinnati Cancer Center researchers will present abstracts at the American Society of Clinical Oncology (ASCO) annual meeting 2023, held in Chicago June 2-6.
May 19, 2023
The University of Cincinnati Cancer Center's Syed Ahmad, MD, is the national principal investigator for a phase 2 trial testing the effectiveness of chemotherapy treatment following surgery for a subset of pancreatic cancer patients.
April 11, 2023
The University of Cincinnati's Atsuo Sasaki, PhD, is leading a multidisciplinary team that received National Institutes of Health funding to learn more about how an enzyme that was previously overlooked helps regulate lysosome and cellular function.
April 14, 2023
University of Cincinnati Cancer Center researchers will present more than a dozen abstracts at the American Association for Cancer Research Annual Meeting 2023, held in Orlando, Florida, April 14-19, including findings that could advance treatments for head and neck and breast cancers.
October 17, 2023
The University of Cincinnati Cancer Center has joined the National Cancer Institute’s Experimental Therapeutics Clinical Trials Network (ETCTN), providing patients with access to cutting edge treatments only available through the network.
September 7, 2022
University of Cincinnati researchers recently published study results in JAMA Otolaryngology showing that administering immunotherapy drug pembrolizumab before surgery for oral cavity cancer did not increase rates of complication during and after surgery.
October 24, 2022
University of Cincinnati researchers presented results from the first-in-human trial of FLASH radiotherapy at the ASTRO 2022 annual meeting, with data suggesting FLASH may hold promise as a potential treatment for tough-to-kill tumors.